Sonova Holding AG (SOON) AI Stock Analysis

• Market Cap: CHF13.67B
• Dividend Yield: 1.89%
• Average Volume (3M): 112.21K
• Price to Earnings (P/E): 25.7
• Beta (1Y): 0.96
• Revenue Growth: 6.58%
• EPS Growth: -10.02%
• Country: CH
• Employees: 18,335
• Sector: Healthcare
• Sector Strength: 51
• Industry: Medical - Devices
• EPS (TTM): 7.07
• Shares Outstanding: 59,626,810
• 10 Day Avg. Volume: 108,225
• 30 Day Avg. Volume: 112,212
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: CHF248.83
• Price Target Upside: 4.73% Upside
• Rating Consensus: Moderate Sell
• Number of Analyst Covering: 7

• Rating: 73 Outperform
• Price Target: CHF260.00 ▲(9.43% Upside)

Sonova Holding AG's strong financial performance is the most significant factor, supported by solid revenue growth and effective cash flow management. Technical analysis provides a cautiously optimistic outlook, while the valuation suggests moderate attractiveness. The absence of earnings call data and corporate events limits additional insights.

Sonova Holding AG Business Overview & Revenue Model

Company Description

Sonova Holding AG is a leading global provider of innovative solutions in the field of audiology. Founded in 1947 and headquartered in Switzerland, the company primarily operates in the hearing care sector, offering a wide range of products and services, including hearing aids, cochlear implants, and wireless communication systems. Sonova's brands, such as Phonak and Unitron, are recognized for their quality and technological advancements, catering to the needs of individuals with hearing impairments across various demographics.

How the Company Makes Money

Sonova generates revenue primarily through the sale of hearing aids and related products, which constitute the bulk of its income. The company operates through multiple channels, including direct sales to consumers, partnerships with audiology clinics, and distribution agreements with hearing care professionals. Additionally, Sonova's revenue model includes ongoing service and maintenance contracts for its devices, as well as accessories and other hearing-related products. Significant partnerships with healthcare providers and advancements in technology, such as Bluetooth connectivity in hearing aids, bolster its market position and drive sales growth. The company also benefits from a strong focus on research and development, allowing it to introduce innovative products that meet evolving consumer demands.

Sonova Holding AG Financial Statement Overview

Summary

Sonova Holding AG exhibits a robust financial position with strong revenue growth, solid profit margins, and effective cost management. The balance sheet is stable with moderate leverage, and cash flow is consistently positive, indicating efficient income conversion and liquidity maintenance.

Income Statement

Sonova Holding AG demonstrates strong revenue growth with a 6.6% increase in the most recent year, alongside solid profit margins. Gross Profit Margin has remained robust at approximately 72% and Net Profit Margin at 14% for the latest fiscal year. The EBIT and EBITDA margins are healthy at 17.9% and 24%, respectively, indicating effective cost management and operational efficiency.

Balance Sheet

The balance sheet shows a stable structure with a Debt-to-Equity Ratio of 0.66, reflecting moderate leverage. The Return on Equity is commendable at 20.3%, indicating effective utilization of equity to generate profits. The Equity Ratio stands at 45%, suggesting a balanced approach between debt and equity financing, though there's room for improvement in reducing liabilities.

Cash Flow

Cash flow analysis reveals consistent positive cash generation with a Free Cash Flow Growth Rate of 5.0%. Operating Cash Flow to Net Income Ratio is strong at 1.47, suggesting efficient conversion of income into cash. The Free Cash Flow to Net Income Ratio is also healthy at 1.21, reflecting the company's ability to maintain liquidity and fund operations effectively.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	3.87B	3.87B	3.63B	3.74B	3.36B	2.60B
Gross Profit	2.78B	2.78B	2.61B	2.59B	2.46B	1.87B
EBITDA	927.00M	927.00M	917.90M	974.50M	893.10M	818.60M
Net Income	540.50M	540.50M	601.00M	647.50M	649.00M	581.00M
Balance Sheet
Total Assets	5.92B	5.92B	5.79B	5.55B	5.59B	5.93B
Cash, Cash Equivalents and Short-Term Investments	687.10M	687.10M	513.80M	414.80M	612.00M	1.77B
Total Debt	1.76B	1.76B	1.79B	1.81B	1.48B	1.83B
Total Liabilities	3.24B	3.24B	3.30B	3.32B	3.16B	3.15B
Stockholders Equity	2.66B	2.66B	2.47B	2.21B	2.41B	2.75B
Cash Flow
Free Cash Flow	656.10M	656.10M	624.70M	609.10M	815.90M	665.50M
Operating Cash Flow	793.70M	793.70M	753.30M	763.40M	922.50M	754.70M
Investing Cash Flow	-212.70M	-212.70M	-234.00M	-429.50M	-707.00M	-123.60M
Financing Cash Flow	-401.80M	-401.80M	-415.30M	-523.50M	-1.37B	687.60M

Sonova Holding AG Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 237.60
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CH:SOON, the sentiment is Positive. The current price of 237.6 is above the 20-day moving average (MA) of 230.39, above the 50-day MA of 230.65, and below the 200-day MA of 262.93, indicating a neutral trend. The MACD of 1.50 indicates Negative momentum. The RSI at 64.25 is Neutral, neither overbought nor oversold. The STOCH value of 78.24 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CH:SOON.

Sonova Holding AG Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SOON	73 Outperform	CHF13.67B	25.70		1.89%	6.58%	-10.02%
STMN	68 Neutral	CHF15.08B	37.73		1.02%	4.49%	45.08%
Sector *	51 Neutral	$7.92B	-0.43	-41.69%	2.21%	22.29%	-1.85%
MEDGF	―	$3.54B	44.31	20.81%	0.45%	―	―
TCHBF	―	$2.48B	33.50	4.57%	1.80%	―	―
0QLQ	―	CHF5.47B	61.33	13.49%	0.55%	―	―
MED	61 Neutral	CHF1.24B	282.78		―	7.29%	-112.70%

Sonova Holding AG Corporate Events

Sonova Shareholders Approve All Board Proposals at 40th General Meeting

At the 40th General Meeting, Sonova shareholders approved all proposals from the Board of Directors, including financial statements, a gross dividend of CHF 4.40 per share, and the re-election of board members. Gilbert Achermann was elected as the new Chairman, succeeding Robert F. Spoerry. The meeting also confirmed Ernst & Young AG as the auditor and approved compensation packages for the Board and Executive Board. These decisions reflect strong shareholder support and ensure continuity in leadership and strategic direction for Sonova.

The most recent analyst rating on (CH:SOON) stock is a Sell with a CHF224.00 price target. To see the full list of analyst forecasts on Sonova Holding AG stock, see the CH:SOON Stock Forecast page.

Sonova Releases 2024/25 Annual Report Highlighting Strong Financial Performance

Sonova Holding AG has released its Annual Report for the fiscal year 2024/25, detailing audited financial statements and corporate strategy insights. The report highlights a sales achievement of CHF 3.9 billion and a net profit of CHF 547 million, underscoring Sonova’s strong market position and operational success. This announcement is significant for stakeholders as it reflects the company’s robust financial health and strategic direction in the hearing solutions industry.

The most recent analyst rating on (CH:SOON) stock is a Sell with a CHF224.00 price target. To see the full list of analyst forecasts on Sonova Holding AG stock, see the CH:SOON Stock Forecast page.